Cytokine interferons

Blatt LM, Davis JM, Klein SB, Taylor MW (1996) The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res 16 489 99... 

Castro A, Suarez D, Inglada L, CarbaUo E, Dominguez A, Diago M, Such J, Del Olmo JA, Perez-Mota A, Pedreira J, Quiroga JA, Carreno V (1997) Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis C. J Interferon Cytokine Res 17 27-30... 

Chang CC, Chen TT, Cox BW, Dawes GN, Stemmer WP, Punnonen J, Patten PA (1999) Evolution of a cytokine using DNA family shuffling. Nat Biotechnol 17 793-797 Chen J, Baig E, Eish EN (2004) Diversity and relatedness among the type I interferons. J Interferon Cytokine Res 24 687-698... 

Enomoto M, Tamori A, Kohmoto MT, Hayashi T, Jomura H, Habu D, Sakaguchi H, Takeda T, Kawada N, Seki S, Shiomi S, Koh N, Nishiguchi S (2007) Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection. J Interferon Cytokine Res 27 201-207... 

Matskevich AA, Cordelier P, Strayer DS (2003) Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis B, J Interferon Cytokine Res 23 709-721... 

Parissis JT, Adamopoulos S, Venetsanou KF, Mentzikof DG, Karas SM, Kremastinos DT. Serum profiles of C-C chemokines in acute myocardial infarction possible implication in postinfarction left ventricular remodeling. J Interferon Cytokine Res 2002 22(2) 223-229. 

Oishi K, Hayano M, Yoshimine H, et al. Expression of chemokine receptors on CD4+ T cells in peripheral blood from HIV-infected individuals in Uganda. J Interferon Cytokine Res 2000 20(6) 597-602. 

Nakaya, T.A. et ah, Panax ginseng induces production of proinflammatory cytokines via toll-like receptor, J Interferon Cytokine Res, 24, 93, 2004. 

Blach-Olszewska Z, Jatczak B, Rak A, Lorenc M, Gulanowski B, Drobna A, Lamer-Zarowska E. (2008) Production of cytokines and stimulation of resistance to viral infection in human leukocytes by Scutellaria baicalensis) flavones. J Interferon Cytokine Res 28 571-581. 

Ohya, K., Matsumura, T., Itchoda, N., Ohashi, K., Onuma, M., and Sugimoto, C. (2005). Ability of orally administered IFN-alpha-containing transgenic potato extracts to inhibit Listeria monocyogenes infection. J. Interferon. Cytokine Res. 25(8) 429 66. 

Poster, G.R., O. Rodrigues, P. Ghouze, E. Schulte-Prohlinde, D. Testa, M.I. Liao, G.R. Stark, L. Leadbeater, and H.C. Thomas, Different relative activities of human cell-derived interferon-alpha subtypes IFN-alpha 8 has very high antiviral potency. I Interferon Cytokine Res, 1996. 16(12) 1027-33. 

Byhardt, R.W., L. Vaickus, PL. Witt, A.Y Chang, T. McAuliffe, J.E. Wilson, C.A. Lawton, J. Breitmeyer, M.E. Alger, and E.C. Borden, Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer. J Interferon Cytokine Res, 1996. 16(11) 891-902. 

Uze, G., G. Lutfalla, and K.E. Mogensen, Alpha and beta interferons and their receptor and their friends and relations. J Interferon Cytokine Res, 1995.15(1) 3-26. 

Reznikov, L.L., A.J. Puren, G Fantuzzi, H. Muhl, L. Shapiro, D.Y Yoon, D.L. Cutler, and C.A. Dinarello, Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8. J Interferon Cytokine Res, 1998.18(10) 897-903. 

Malmgaard L. Induction and regulation of IFNs during viral infections. 7 Interferon Cytokine Res. 2004 24 439 154. 

M. Rogge, N. Gillette, B. Niggemann, and J. Green. 2002. Safety and systemic absorption of pulmonary delivered human IFN-betala in the nonhuman primate comparison with subcutaneous dosing./. Interferon Cytokine Res. 22 709-717. 

DeLeo, J. A., Colburn, R. W., Nichols, M., and Malhotra, A. (1996). Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16, 695—700. 

Williams GJ, Witt PL. Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX. I Interferon Cytokine Res 1998 18(11) 967-75. 

Sturzebecher S, Maibauer R, Heuner A, Beckmann K, Aufdembrinke B. Pharmacodynamic comparison of single doses of IFN-betala and IFN-betalb in healthy volunteers. I Interferon Cytokine Res 1999 19(ll) 1257-64. 

Schellekens H, Ryff JC, van der Meide PH. Assays for antibodies to human interferon-alpha the need for standardization. J Interferon Cytokine Res 1997 17(Suppl l) S5-8. 

Hochuli, E. (1997), Interferon immunogenicity Technical evaluation of interferon-alpha 2a, J. Interferon Cytokine Res., 17 (Suppl 1), 15-21. 

Robinson CM, Hale PT, Carhn JM (2005) The role of IFN-gamma and TNF-alpha-responsive regnlatory elements in the synergistic indnction of indoleamine dioxygenase. J Interferon Cytokine Res 25 20-30. 

Tomkins WA (1999) Immunomodulation and therapeutic effects of the oral use of interferon-alpha mechanism of action. J Interferon Cytokine Res 19 817-828. 

Krown SE, Li P, Von Roenn JH, Paredes J, Huang J, Testa MA. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi s sarcoma a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res 2002 22(3) 295-303. 

Borgia G, Reynaud L, Gentile I, Cerini R, Ciampi R, Dello Russo M, Piazza M. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. J Interferon Cytokine Res 2001 21(7) 469-70. 

McKenna RM, Oberg KE. Antibodies to interferon-alpha in treated cancer patients incidence and significance. J Interferon Cytokine Res 1997 17(3) 141-3. 

Dolen JG, Mathur A. Undetectable interferon-a serum levels in a patient with atopic dermatitis. J Interferon Cytokine Res 1995 15 973-5. 

Joyce DA, Steer JH. Tumor necrosis factor a and interleukin-1 a stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes. J Interferon Cytokine Res 1995 15 947-54. 

Vanky F, Rising C, Sjowall K, et al. Interferon-gamma and tumor necrosis factor-a treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes, f Interferon Cytokine Res 1996 16 201-7,... 

---